Abstract
Background: BarricorTM lithium heparin plasma tubes are new blood tubes that have been introduced to overcome the effects of gel in serum separator tubes (SST) and the shortcomings of standard lithium heparin plasma. We aimed to evaluate BarricorTM tubes as an alternative to serum separator tubes and compare the stability between the tubes.
Methods: Forty-four paired samples were collected using both BarricorTM and SST. We compared five analytes at baseline (<6h) and after every 24h using the Passing-Bablok and Bland-Altman plots. Aspartate aminotransferase (AST), potassium (K), phosphate (PO4), lactate dehydrogenase (LDH), and creatinine were analysed in both tubes. We calculated the percentage difference for each analyte between the baseline and time intervals to assess analyte stability. The percentage difference was compared to the desirable specification for bias and reference change value (RCV).
Results: All analytes were comparable at baseline. Statistical differences (p<0.001) became evident after 24h. PO4, K, and creatinine had a mean difference that exceeded the desirable specification for bias (-9.59%, -9.35%, and -4.59%, respectively). Potassium was stable up to 24h in both tubes. LDH showed better stability in SST (144h vs. 96h). PO4 concentrations were more stable in both tubes with the SST (96h vs. 72h). Creatinine and AST had the longest stability in both tubes compared to other analytes (144h).
Conclusions: Data demonstrated variability and similarities in analyte concentrations and stability, respectively in both tubes
Keywords
Array
Array
References
The published articles will be distributed under the Creative Commons Attribution 4.0 International License (CC BY). It is allowed to copy and redistribute the material in any medium or format, and remix, transform, and build upon it for any purpose, even commercially, as long as appropriate credit is given to the original author(s), a link to the license is provided and it is indicated if changes were made. Users are required to provide full bibliographic description of the original publication (authors, article title, journal title, volume, issue, pages), as well as its DOI code. In electronic publishing, users are also required to link the content with both the original article published in Journal of Medical Biochemistry and the licence used.
Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.